| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $64.46K | $63.75K | $57.72K | $64.71K | $89.79K |
| R&D | – | – | – | – | – |
| SG&A | $1.56K | $1.71K | $530.00 | $724.00 | $11.70K |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$64.46K | -$63.75K | -$57.72K | -$64.71K | -$89.79K |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | 0.0000 | 0.0000 | – | – | – |
| Shares (diluted) | $760.25M | $760.25M | – | – | – |